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Abstract

Key Points

IMPORTANCE It remains poorly understood how parents decide whether to enroll a child in a
neonatal clinical trial. This is particularly true for parents from racial or ethnic minority populations.
Understanding factors associated with enrollment decisions may improve recruitment processes for

Question How do parents with infants
enrolled in a neonatal clinical trial differ
from those who decline participation?
Findings In this survey study including

families, increase enrollment rates, and decrease disparities in research participation.

269 parent responses, participants who

OBJECTIVE To assess differences in parental factors between parents who enrolled their infant and

enrolled their infant had different

those who declined enrollment for a neonatal randomized clinical trial.

demographic characteristics (lower rate
of Medicaid participation, higher

DESIGN, SETTING, AND PARTICIPANTS This survey study conducted from July 2017 to October

income, less likely to identify as Black),

2019 in 12 US level 3 and 4 neonatal intensive care units included parents of infants who enrolled in

reported their infant’s medical condition

the High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) trial or who were eligible but

as more serious, and reported higher

declined enrollment. Data were analyzed October 2019 through July 2020.

trust in medical researchers compared
with those who declined to enroll. There
was no association between study

EXPOSURE Parental choice of enrollment in neonatal clinical trial.

comprehension and enrollment.

MAIN OUTCOMES AND MEASURES Percentages and odds ratios (ORs) of parent participation as
categorized by demographic characteristics, self-assessment of child’s medical condition, study
comprehension, and trust in medical researchers. Survey questions were based on the hypothesis
that parents who enrolled their infant in HEAL differ from those who declined enrollment across 4
categories: (1) infant characteristics and parental demographic characteristics, (2) perception of
infant’s illness, (3) study comprehension, and (4) trust in clinicians and researchers.

Meaning Differences between parents
who enrolled their infant and those who
declined suggest potential targets for
future research aiming to better engage
underrepresented groups in neonatal
clinical research.

RESULTS Of a total 387 eligible parents, 269 (69.5%) completed the survey and were included in
analysis. This included 183 of 242 (75.6%) of HEAL-enrolled and 86 of 145 (59.3%) of HEAL-declined
parents. Parents who enrolled their infant had lower rates of Medicaid participation (74 [41.1%] vs
47 [55.3%]; P = .04) and higher rates of annual income greater than $55 000 (94 [52.8%] vs 30
[37.5%]; P = .03) compared with those who declined. Black parents had lower enrollment rates
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Author affiliations and article information are
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compared with White parents (OR, 0.35; 95% CI, 0.17-0.73). Parents who reported their infant’s
medical condition as more serious had higher enrollment rates (OR, 5.7; 95% CI, 2.0-16.3). Parents
who enrolled their infant reported higher trust in medical researchers compared with parents who
declined (mean [SD] difference, 5.3 [0.3-10.3]). There was no association between study
comprehension and enrollment.
CONCLUSIONS AND RELEVANCE In this study, the following factors were associated with neonatal
clinical trial enrollment: demographic characteristics (ie, race/ethnicity, Medicaid status, and
(continued)
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Abstract (continued)

reported income), perception of illness, and trust in medical researchers. Future work to confirm
these findings and explore the reasons behind them may lead to strategies for better engaging
underrepresented groups in neonatal clinical research to reduce enrollment disparities.
JAMA Network Open. 2021;4(1):e2032106. doi:10.1001/jamanetworkopen.2020.32106

Introduction
Clinical trials are essential to advance neonatal care, but recruitment for them can be ethically
complex. Because infants cannot provide consent for themselves,1 parents or guardians are asked for
their permission.2 Recruitment can also be challenging because parents are under significant strain,
and their vulnerable, sick infants often must be enrolled quickly if they are to participate.3-6
There are limited data to explain how parents decide whether to participate in neonatal clinical
trials. Previous research has struggled to include the views of those who decline neonatal research7,8
with only a few exceptions.9,10 Low enrollment rates within neonatal clinical trials diminish the
quality of data collected and limit the generalizability of results.11 Racial and ethnic disparities exist in
neonatal research enrollment, but we do not fully understand which groups are overrepresented or
underrepresented.12,13 Other parental factors that are potentially important in enrollment decisions
include study comprehension9,14 and medical trust.7,15,16 Understanding these factors may enable
researchers to improve recruitment processes, optimize enrollment rates, and decrease disparities in
research participation.
The High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) trial was a multisite
randomized clinical trial (RCT) assessing erythropoietin as a neuroprotectant for infants with
moderate to severe neonatal encephalopathy.17 Infants eligible for HEAL had an estimated
gestational age greater than 36 weeks with moderate or severe neonatal encephalopathy
undergoing therapeutic hypothermia. This population has a high risk of death in the neonatal period
(approximately 28%) and of neurodevelopmental impairment among survivors (approximately
20%).18 We sought to identify differences between parents who enrolled and those who declined
enrollment. We evaluated 4 categories: (1) infant characteristics and parental demographic
characteristics, (2) parental perception of infant’s illness, (3) parental study comprehension, and (4)
parental trust in clinicians and researchers.

Methods
Survey Development
We administered a survey to parents of infants approached for enrollment in the HEAL trial. The
survey instrument was developed using: (1) validated question scales where available,19,20 (2)
questions from previous surveys on parental participation in pediatric research,9,16,21 and (3)
questions created after input from experts in survey design, medical decision-making, clinical trials,
neonatology, and research ethics. We received feedback from the neonatal intensive care unit (NICU)
parent advisory council at the University of Washington. This study followed American Association
for Public Opinion Research (AAPOR) reporting guideline for best practices including survey design
(ie, utilizing conceptual modeling, questionnaire pretesting), standardized administration, and clear
reporting.22 Institutional review board (IRB) approval was received at each of the 12 participating sites
and at subsites where applicable. Each IRB made the determination whether permission to participate
was obtained by written informed consent, by oral assent, or if the survey was granted a waiver.
Infant characteristics included for analysis were birth weight, estimated gestational age at birth,
whether inborn (recruited for HEAL at birth hospital) or outborn (transferred from another hospital),
Medicaid status, severity of neonatal encephalopathy based on Sarnat exam prior to 6 hours of age,23
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and day of life of survey. Parental demographic variables included gender, education, household
income, prior experience with medical research, other children, race and ethnicity, and language
spoken at home. Infant characteristics were obtained from the medical record; all other reported
data were obtained via survey.
Parental perception of their infant’s condition was assessed using 7 novel questions. Responses
were recorded on a 5-point Likert scale from 1 (“not at all”) to 5 (“very much”). Higher scores
indicated increased concern of illness severity. Parental comprehension of the HEAL trial was
assessed by 10 novel true-false questions. Questions addressed details of the HEAL trial,
voluntariness of participation, and follow-up requirements. Trust was measured using 3 preexisting
validated scales with minor adjustments in wording to fit the patient population: Hall’s 4-item trust in
medical research scale19 and Dugan’s 5-item trust in the medical profession and 5-item trust in a
physician scales.20
Surveys were refined using cognitive interviews with 10 parents of NICU patients by a single
trained interviewer (E.M.W.) to assess comprehension and interpretation. The final survey was
translated into Spanish by a certified medical translation service. Study data were collected and
managed using REDCap electronic data capture tools (REDCap Consortium) hosted at the University
of Washington.24,25 Both English and Spanish versions of the survey were inputted into the REDCap
platform.

Recruitment
Surveys were fielded at 12 of 17 HEAL sites from July 28, 2017, to October 30, 2019. All parents
approached for HEAL trial enrollment were eligible. Parents of infants who were ineligible and those
who were eligible but not enrolled for other reasons (eg, unavailability of study drug or research
coordinator) were excluded. Given the acute stressors of neonatal encephalopathy diagnosis and
deciding on enrollment in a clinical trial, eligibility did not begin until the infant’s fifth day of life. Each
family could choose 1 parent to participate until their infant’s hospital discharge or death.
Interviewers read questions aloud to parents and entered responses directly into REDCap to
minimize transcription errors. Interviewers were excluded from surveying families they had
approached for HEAL RCT participation. Preference was given for in-person administration, but the
survey was administered over phone when necessary. After survey completion, parents were offered
a gift card or small toy based on local IRB preference. A Spanish language version of the survey was
offered to families using a Spanish language speaking interviewer or via interpreter, if necessary.

Variables
We combined self-reported race and ethnicity into 4 mutually exclusive categories: Hispanic,
non-Hispanic Black (hereafter “Black”), non-Hispanic White (hereafter “White”), and non-Hispanic
other (ie, Asian, American Indian or Alaska Native, Native Hawaiian or other Pacific Islander), as has
been done previously and is consistent with the US Census Bureau approach.26
To simplify analysis, we dichotomized the 5-point responses for each question set (eg, for
parental perception of infant’s illness, 1-3 was categorized as “less concerned” and 4-5 as
“concerned”).

Statistical Analysis
Standard descriptive statistics were applied to our factors of interest. We fit several multivariate
logistic regression models to investigate the associations of parental factors (ie, demographic
characteristics, perception of infant’s illness, study comprehension, and trust scales) with enrollment
decision. We examined the association between each parental factor and enrollment decision by
comparing odds ratios (ORs) between groups. In each model, we adjusted for race, Medicaid status,
and household income to eliminate potential confounding. We report estimates of ORs along with
95% confidence intervals constructed using robust standard errors.
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Data were analyzed October 2019 through July 2020. All P values are 2-sided and not adjusted
for multiple comparisons; an association was considered significant if P < .05. We performed a
planned secondary analysis to evaluate the interaction between race/ethnicity and each of the
parental factors separately to assess whether each factor was differentially associated with
enrollment by race. All analyses were conducted using the R statistical package version 3.6.1 (R
Project for Statistical Computing).

Results
Infant Characteristics and Parental Demographics
Analysis included 269 of 387 (69.5%) eligible parents across 12 US sites who completed the survey.
Of these, 177 (67.0%) participants were mothers, 121 (45.7%) were receiving Medicaid, and 124
(48.1%) reported income $55 000 or greater. Self-reported race/ethnicity of participants was 148
(55.0%) White, 61 (22.9%) Hispanic, and 39 (14.5%) Black (Table 1). Surveys captured 183 of 242
(75.6%) HEAL-enrolled and 86 of 145 (59.3%) HEAL-declined parents. The 86 parents who declined
HEAL and participated in our survey included 1 who did not respond after approach by study staff,
16 who did not wish to talk to study staff, and 69 who declined trial participation after discussion with
study staff. There were no significant differences in infant characteristics between the 2 groups
(Table 1). Parents of infants who were not receiving Medicaid or who reported higher income were

Table 1. Infant Characteristics and Parental Demographic Characteristics
Participants, No. (%)
Characteristics

All

Enrolled

Declined

Totala

269

183 (68.0)

86 (32.0)

Birth weight, mean (SD), g

3409 (631)

3434 (602)

3356 (688)

Estimated gestational age, mean (SD), wk

39.1 (1.4)

39.1 (1.4)

39.0 (1.5)

Inborn

46 (17.1)

32 (17.5)

14 (16.3)

Severe encephalopathy

46 (17.1)

30 (16.4)

16 (18.6)

Infant day of life on survey, mean (SD)

9.5 (7.8)

9.0 (7.2)

10.4 (8.8)

Age of respondent, mean (SD), y

29.6 (6.4)

29.9 (6.4)

29.0 (6.3)

Mother respondent

177(67.0)

120 (66.3)

57 (68.7)

Medicaid recipientb

121(45.7)

74 (41.1)

47 (55.3)

Education
Some high school or high school graduate

82 (30.8)

52 (28.6)

30 (35.7)

Some college

59 (22.2)

39 (21.4)

20 (23.8)

≥College graduate

125 (47.0)

91 (50.0)

34 40.5)

Income ≥$55 000/yb

124(48.1)

94 (52.8)

30 (37.5)

Past research experience

42 (15.7)

28 (15.3)

14 (16.7)

Other children

106 (39.7)

71 (38.8)

35 (41.7)

With chronic health problems

8 (7.5)

8 (11.3)

0

Who had been in NICU

14 (13.2)

10 (14.1)

4 (11.4)

English spoken at home

240 (90.2)

164 (90.1)

76 (90.5)

Survey administered in Englishc

257 (96.6)

174 (96.1)

83 (97.6)

61 (22.9)

43 (23.6)

18 (21.4)

Black

39 (14.5)

19 (10.4)

20 (23.3)

White

148 (55.0)

108 (59.0)

40 (46.5)

Asian

10 (3.7)

7 (3.8)

3 (3.5)

American Indian or Alaska Native

6 (2.2)

4 (2.2)

2 (2.4)

Race/ethnicityb
Hispanic

Abbreviation: NICU, neonatal intensive care unit.

Non-Hispanic

Native Hawaiian or Other Pacific Islander

2 (0.7)

1 (0.5)

1 (1.2)

Other

2 (0.7)

1 (0.5)

1 (1.2)
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Percentages are calculated that exclude missing data
in the denominator.

b

P value for Medicaid status = .04; for reported
income, P = .03; and for race, P = .04; all other P
values not significant.
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Surveys could be administered in English only at 1
site and in English or Spanish at 11 sites.
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significantly more likely to enroll their children in the study (eg, Medicaid recipients vs annual income
ⱖ$55 000 enrollment: 74 (41.1%) participants vs 94 (52.8%) participants; Table 1). Enrollment status
was significantly different between race/ethnicity groups, with lowest relative enrollment among
Black parents compared with White parents (OR, 0.35; 95% CI, 0.17-0.73). In a planned secondary
analysis, none of the interactions between race/ethnicity and other parental factors were significant.

Perception of Infant’s Illness
We observed significant differences in parental perception of their infant’s condition. Parents who
enrolled their infant in HEAL reported their infant’s medical condition to be more serious compared
with parents who declined for 4 of 7 questions (eg, enrollment and agreement with the statement, “I
very much or moderately thought my infant’s illness was a serious medical condition,” ⱖ4 on a
5-point scale: OR, 5.7; 95% CI, 2.0-16.3) (Table 2). After adjusting for race, Medicaid status, and
household income, the association between parental perception of illness and enrollment remained
significant. The association between parental perception of their infant’s illness and study enrollment
did not differ by race, reported income, or Medicaid status.
Because we found this association between parental perception of illness and enrollment, we
looked for an association between parental perception of illness and Sarnat classification. The
percentage of parents who responded that they “very much” or “moderately” thought their infant
was sick was higher for parents of infants with severe Sarnat stage (41 of 46 [89%]) compared with
parents of infants with moderate Sarnat stage (166 of 221 [75%]) (OR, 3.2; 95% CI, 1.2-11.0) (eTable in
the Supplement). For each of the other 6 questions related to parental perception of their infant’s
illness, the association with Sarnat classification was not significant.
We asked a single question on parental self-assessment of understanding of their infant’s illness:
“How much did you understand your infant’s illness?” Self-assessment of understanding of their
infant’s illness did not differ between parents who enrolled in HEAL and those who declined. Roughly
half of respondents self-reported a low level of understanding of their infant’s condition.

Comprehension of HEAL Study
Parental comprehension was high, with a mean (SD) of 8.9 (1.2) out of 10 questions answered
correctly; the median (interquartile range) number of correct answers was 9.0 (8.0-10.0). Total
correct answers did not differ significantly between those who did and did not enroll in HEAL
(Table 3).

Trust of Clinicians and Researchers
Enrolled parents reported significantly higher levels of trust in medical researchers compared with
parents who declined (mean [SD] score, 71.7% [17.2%] vs 64.8% [20.8%]) (Table 4). There was no
difference in reported trust in the medical profession (61.7% [13.7%] vs 60.1% [13.0%]) or trust in the
infant’s neonatologist between groups (70.3% [11.6%] vs 70.1% [11.1%]). After adjusting for race,
Medicaid status and household income, the association of trust in medical researchers with

Table 2. Parental Perception of Infant’s Condition
Participants, No. (%)
I very much or moderately…a

All

Enrolled

Declined

Odds ratio
(95% CI)b

… thought my infant’s illness would affect his or her life

187 (69.8)

145 (79.2)

42 (49.4)

3.6 (2.0-6.5)

… thought my infant was sick

207 (77.5)

148 (81.3)

59 (69.4)

1.8 (0.9-3.4)

… was concerned about my infant’s illness

258 (96.3)

181 (98.9)

77 (90.6)

8.4 (1.6-43.2)

… understood my infant’s illness

127 (47.4)

85 (46.4)

42 (49.4)

0.9 (0.5-1.5)

… thought my infant’s illness was a serious condition

245 (92.8)

175 (96.7)

70 (84.3)

5.7 (2.0-16.3)

… thought my infant’s illness would have long term
effects

186 (69.7)

141 (77.0)

45 (53.6)

2.7 (1.5-5.0)

I thought my infant was likely to die at birthc

133 (50.8)

95 (53.7)

38 (44.7)

1.3 (0.7-2.3)
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Number (%) of participants responding 4 or 5 on
5-point scale from 1 (not at all) to 5 (very much).
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Odds ratio is that of enrollment in HEAL comparing a
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selected 1 to 3 on the first 6 questions, and yes to no
for last question. Ratios are adjusted for race,
Medicaid status, and household income.

c

No. (%) of participants answering “yes.”
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enrollment decision remained significant (mean difference, 5.3%; 95% CI, 0.3%-10.3%). The
association between trust and study enrollment did not differ by race, reported income, or
Medicaid status.

Discussion
This study lends insight into factors associated with parental decision-making that can inform future
strategies to improve enrollment for neonatal RCTs. First, rates of participation differed by race and
income. Second, although Sarnat classification of objective illness severity did not differ between
groups, parents who declined HEAL enrollment felt their infant was less ill than those who enrolled.
Third, there was no association between study comprehension and enrollment. Fourth, a specific
decreased trust in medical researchers may be driving lower enrollment rates, rather than general
medical distrust.

Infant Characteristics and Parental Demographic Characteristics
We found lower enrollment among parents on Medicaid and with lower incomes. These findings are
consistent with previously observed recruitment disparities in adults from underserved
populations.27 In pediatrics, the relationship between socioeconomic status (SES) and research
enrollment is poorly described, and with conflicting results.10,16,28 We also found that Black parents
enrolled their infants in HEAL less frequently than White parents. The association between the

Table 3. Study Comprehension
Correct responses, No. (%)
Characteristics

All
(n = 269)

Enrolled
(n = 183)

Declined
(n = 86)

P value

All infants who joined HEAL would receive Epo

229 (87.4)

164 (90.1)

65 (81.2)

.07

Epo has never been used in infants before

223 (86.1)

160 (87.9)

63 (81.8)

.27

Infants who joined HEAL would have a 50:50 chance of receiving
placebo or Epo

248 (94.7)

176 (96.7)

72 (90.0)

.05

Infants with brain injury at birth are at high risk of long-term
neurologic problems

242 (92.0)

169 (92.3)

73 (91.2)

.96

The purpose of the HEAL study is to find out if Epo can protect
infants with brain injury at birth from developing neurologic
problems

255 (97.0)

176 (96.7)

79 (97.5)

>.99

Infants in the HEAL study may have more blood drawn for
analysis

220 (84.6)

157 (85.8)

63 (81.8)

.53

Infants in the HEAL study will get more blood transfusions

227 (88.3)

165 (90.7)

62 (82.7)

.11

Doctors know that Epo can protect infants with brain injury at
birth from having neurologic problems

166 (63.8)

108 (60.0)

58 (72.5)

.07

Participation in the HEAL study was optional

263 (99.6)

182 (99.5)

81 (100)

1.0

Infants in the HEAL study are followed through age 2 y

244 (93.8)

176 (96.2)

68 (88.3)

.03

Total score correct answers, mean (SD)

8.9 (1.2)

9.0 (1.3)

8.7 (1.2)

.05

Abbreviation: Epo, erythropoietin; HEAL, High-dose
Erythropoietin for Asphyxia and Encephalopathy.

Table 4. Parental Trust
Score, mean (SD)
Survey prompt

All

Enrolled

Declined

Mean difference (95% CI)d

Trust in medical researchersa

69.5 (18.7)

71.7 (17.2)

64.8 (20.8)

5.3 (0.3 to 10.3)

Trust in medical professionb

61.2 (13.5)

61.7 (13.7)

60.1 (13.0)

1.5 (−2.1 to 5.1)

Trust in your infant’s neonatologistc

70.3 (11.4)

70.3 (11.6)

70.1 (11.1)

−0.3 (−3.5 to 2.9)

a

19

Using Hall’s 4-item trust in medical research scale with mean (SD) score indexed to a 100-point scale.

b

Using Dugan’s 5-item patient trust in the medical profession scale20 with mean (SD) score indexed to a 100-point scale.

c

Using Dugan’s 5-item trust in a physician scale20 with mean (SD) score indexed to a 100-point scale.

d

Adjusted for race, Medicaid status, and household income.
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parental factors we studied (perception of their infant’s illness, medical trust, and study
comprehension) and HEAL enrollment did not differ by race, Medicaid status, or reported income.
Black participants are the most underrepresented within US research in adults.29,30 While some
have emphasized historical abuse and persistent distrust in medical research,31 others have
emphasized limited access to clinical trials.32 Other factors that may contribute to disparities in
research participation include implicit and explicit biases of research team members and financial or
transportation barriers.33-35 Establishing community partnerships and building relationships with
underrepresented populations are also important.27 Enrollment of racial and ethnic minorities in
pediatric clinical research, though less well-studied, is lower than for White children including within
critical care,28,36 oncology,37 and neonatology.11,12 Conversely, assessments of published articles in
3 general pediatric journals found overrepresentation of Black participants and underrepresentation
of Hispanic participants when comparing with US Census Bureau data.13,38 The lack of clarity
highlights the need for more work in this area.
Contributors to disparities in clinical trial participation are complex and will require multilevel
solutions.39 Racism and poverty are both social determinants of health that profoundly impact
pediatric health outcomes.40,41 Neonatal outcomes in the US are worse for Black infants42-47 and for
infants from families with low SES.48 Populations that are systematically underrepresented in
neonatal research fail to benefit from research, which could exacerbate existing disparities in
neonatal clinical outcomes.45 Future work must study these disparities and other potential drivers of
differences in enrollment to improve representation within neonatal research and address persistent
injustices.

Parental Perception of Infant’s Condition
We found that parents who enrolled their infants in HEAL reported perceiving their infant’s medical
condition to be more serious compared with those who declined HEAL enrollment. Although we do
not have additional data describing illness severity, the Sarnat scores23 in the 2 groups were
equivalent. This suggests that the groups were comprised of infants with similar illness severity at
time of HEAL enrollment. Thus, the most likely reason for this finding is that parents were more likely
to decline HEAL because of an incorrect assessment that their child was less sick than they were.
Believing an infant to be gravely ill might make a parent more willing to enroll in research.49,50
Importantly, all infants eligible for HEAL were at high risk for neurodevelopmental impairment.
Future work should evaluate how illness perception may influence enrollment decisions. If
parental perception of illness severity mediates the decision to enroll, then an intervention that
improves parental understanding of their infant’s medical condition may both improve the quality of
clinical decision-making and increase enrollment for neonatal clinical trials.
Future work should evaluate the contributors to parental perception of their infant’s illness.
Such work must gather more granular clinical data to better understand how parents develop their
perception of their infant’s illness. Considering the HEAL eligible population, for example, it would be
useful to know short-term (eg, intubation or pressor requirement), medium-term (eg, MRI findings,
neurological exam, and feeding support requirements at discharge), and long-term (eg, 2-year
neurodevelopmental assessment) outcomes, in addition to how perception of illness may change
over time.

Study Comprehension
Although study comprehension is an enduring challenge for clinical trial enrollment51 and has been
posited as a reason for lower enrollment of racial and ethnic minorities and individuals of lower
SES,9,14 we did not find differences in study comprehension between parents who enrolled and those
who did not enroll in neonatal research. Researchers were able to educate parents to achieve high
levels of comprehension about the HEAL study. This suggests that study comprehension was not a
major problem among parents approached for the HEAL trial. Future work must assess the role of
study comprehension for enrollment decisions in other neonatal clinical trials.
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Trust
We found higher levels of trust in medical researchers among enrolled parents compared with
parents who declined, but no difference in trust in clinicians on 2 trust scales. The higher trust in
medical researchers among enrolled parents is consistent with reflections of experienced NICU
clinical researchers15 as well as interview7 and survey16 studies of parents considering research
participation.
Our findings are novel because they add nuance to the existing literature on the relationship
between trust and parental decision to enroll in pediatric research.7,16 Our findings suggest it is not
simply global trust in medicine, but a particular kind of trust—that of medical researchers—which may
mediate enrollment decisions. There has been growing attention to race/ethnicity concordance
between participants and research staff as part of research engagement with underrepresented
populations.52 The relationship between concordance, trust in medical researchers, and research
participation remains poorly described. For example, a 2020 study53 found greater clinical trial
attrition among race/ethnicity concordant dyads compared with discordant dyads. Such findings,
paired with the pragmatic challenges of implementation,54 highlight the complexity of these issues.
Future work should assess whether interventions to build trust in researchers and other study
personnel, whether at the community or individual level, can increase enrollment for neonatal
clinical trials.

Limitations
This study had several limitations. Although we succeeded in including a large number who declined
participation in HEAL, families who declined survey participation might differ from those who participated. Characteristics of the HEAL eligible population and of the HEAL study may have influenced the
enrollment decision in unknown ways that may impact generalizability. We did not assess recruitment
practices (eg, tracking of potential participants, research team composition, method of contact with
families), which varied across sites and may influence enrollment.55 Our eligibility window (infant’s fifth
day of life through hospital discharge) may have affected recall.56 Although we asked parents to answer
questions thinking back to the time of enrollment, responses may have been influenced by subsequent
events. We did not assess trust in research institutions, which may be important and different than trust
in medical researchers.57 We did not evaluate race/ethnicity concordance between parents and research staff. Our questions about illness perception, based on previous work suggesting parental perception of illness severity and urgency influences clinical decision-making in the NICU,58,59 have not
been validated. Our study comprehension questions may not have been at the right level of difficulty to
capture the full range of parental understanding.

Conclusions
This study identified the following factors associated with whether a parent enrolled their child in a
neonatal clinical trial: demographic characteristics (ie, reported parental race/ethnicity, infant’s
Medicaid status, and reported parental income), perception of infant’s illness severity, and trust in
medical researchers. We found lower rates of enrollment among Black parents compared with White
parents, parents with lower income compared with those with higher income, parents who
perceived their infant as less severely ill, and parents with lower trust in medical researchers. Future
work should seek to confirm our findings in other neonatal clinical trials and explore the reasons
behind them. In particular, greater understanding of how parents evaluate their infants’ clinical
condition and how this influences clinical trial enrollment is critically important. Future work should
also assess strategies for better engaging underrepresented groups in neonatal clinical research and
reducing enrollment disparities. Understanding the differences between parents who enroll and
those who do not enroll their infant in neonatal clinical trials will help identify interventions to
improve enrollment and ensure that the results and benefits of research are more accurate and
equitable.
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